New Delhi : The National Pharmaceutical Pricing Authority (NPPA) has capped trade margins on the Maximum Retail Price (MRP) of 137 anti-cancer drugs. The authority, which comes under the Department of Pharmaceuticals in the Ministry of Chemicals and Fertilizers, acted on the recommendations of an Expert Committee that the Directorate General of Health Services constituted on 17 October 2026. The revised MRPs take effect from 9 November 2026.
As of 8 November, 85 pharmaceutical companies had reported revised MRPs for 1,364 anti-cancer formulations covering 121 drugs. A total of 679 brands have cut prices by more than 50 per cent, and the largest reduction reported is 96.45 per cent. The price cuts are expected to save consumers about ₹3,540.38 crore a year.
Consumers can check the revised MRP printed on the medicine pack, or verify prices on the Pharma Sahi Daam mobile app or the NPPA website, nppa.gov.in. No chemist or hospital pharmacy can charge more than the revised MRP. Overcharging and other pricing complaints can be registered on the Pharma Jan Samadhan portal or with the NPPA helpline at 1800-111-255.